Home » Topics » Disease categories and therapies » Immune

Immune
RSS

MedImmune's UTI vaccine enters second phase II trial

March 14, 2001

Hollis-Eden files IND for clinical evaluation of HE-2200

March 14, 2001

Renal function improves upon replacement of calcineurin inhibitors with mycophenolate mofetil

March 13, 2001

Heterocyclic compounds from Sankyo act as Th1-selective immunosuppressants

March 2, 2001

Treatment of T-cell-mediated diseases with new quinazoline derivatives

Feb. 26, 2001

Nabi StaphVAX elicits antibodies against resistant S. aureus strains

Feb. 26, 2001

Improved nucleoside immunomodulators in the ICN pipeline

Feb. 22, 2001

Chlamydia polypeptide and use in DNA vaccines

Feb. 21, 2001

BASB113 polynucleotides and polypeptides for use as vaccines

Feb. 21, 2001

New tuftsin analogues more potent than the parent compound and orally active

Feb. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...